MedTrace Logo

Physiotherapy Applications in Lateral Epicondylitis

NCT07028840 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2025-06-25

No results posted yet for this study

Summary

This study aims to compare the effectiveness of extracorporeal shock wave therapy (ESWT) and high-intensity laser therapy (HILT) in improving pain, grip strength, and function in patients with lateral epicondylitis. A total of 42 volunteer patients aged 18-65 were enrolled at Balıkesir Private Sevgi Hospital physical medicine polyclinic. Participants were randomly assigned into three groups: group 1 received conventional physiotherapy, group 2 received physiotherapy plus ESWT, and group 3 received physiotherapy plus HILT. Physiotherapy was applied for 2 weeks, totaling 10 sessions. ESWT and HILT were each administered twice weekly for 2 weeks, totaling 4 sessions. Pain was measured using the visual analog scale (VAS), grip strength with a hand dynamometer, and function using the Duruöz Hand Index and PRTEE-T questionnaire. Evaluations were performed before treatment, after 2 weeks, and one month post-treatment.

Conditions

  • Lateral Epicondylitis

Interventions

OTHER

Physiotherapy

10 sessions over 2 weeks, including TENS, cold therapy, ultrasound, and exercise therapy, 5 sessions per week.

DEVICE

Extracorporeal Shock Wave Therapy (ESWT)

4 sessions total, applied 2 times per week for 2 weeks.

DEVICE

High-Intensity Laser Therapy (HILT)

4 sessions total, applied 2 times per week for 2 weeks.

Sponsors & Collaborators

  • Pamukkale University

    lead OTHER

Principal Investigators

  • SUAT EREL, PROF.DR. · PAMUKKALE UNİVERSİTY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-10
Primary Completion
2020-09-05
Completion
2020-12-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07028840 on ClinicalTrials.gov